PHAR (Pharming Group N.V.) Pangali Forward P/E
Pharming Group N.V. relies on a steady cash flow from orphan drug sales to fund new research. The company's forward P/E, which informs this chart via GURU.Markets data, currently stands at 34.60. The business maintains monopoly control over protein production within a narrow niche, while a team of leading biologists is driven by the opportunity to save patients' lives.
Rincian analitis perusahaan Pharming Group N.V.
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Pharming Group N.V.|PHAR - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Pharming Group N.V.|PHAR - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Pharming Group NV|PHAR - Utang jangka dawa|Utang jangka cendhak perusahaan Pharming Group|Rasio cepet pharming.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
PHAR - Bathi pungkasan|Proyeksi bathi mangsa ngarep Pharming Group N.V.|PHAR - Pangali P/E|Rega marang bathi mangsa ngarep Pharming|PHAR - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pharming Group NV|PHAR - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Pharming Group|PHAR - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan pharming.com|PHAR - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Pharming Group N.V.
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:Pharming Group
Investors use this indicator to identify fundamental valuation supports for an asset. The metric is calculated as the ratio of the current share price to the projected earnings for the upcoming period. The forward P/E history of Pharming Group N.V. (PHAR) visualizes the dynamics of market expectations and the impact of the cost of capital on the business valuation. A compression of the multiple reflects the risks of losing market share. For Pharming Group N.V. (PHAR), this is critical due to pressure from genetic engineering behemoths in the orphan disease niche.
Pesaing Pharming Group N.V. (PHAR)
Prakiraan rega marang bathi ARGX (argenx)|BNTX (BioNTech Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (abivax.com)|Kapitalisasi marang proyeksi bathi ADMA Corp (ADMA)|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|Kiniksa (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols SA|Prakiraan rega marang bathi ADPT|Pangali Forward P/E Celldex Corp|Rega marang bathi mangsa ngarep Aurinia Pharmaceuticals (AUPH)|biocryst.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake ABCL|TRML: Pangali Forward P/E|precigen.com - Pangali mangsa ngarep rega marang bathi|NKTR (Nektar Therapeutics Inc.) - Pangali Forward P/E|Pangali Forward P/E Upstream Bio, Inc.|Rega marang bathi mangsa ngarep Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Gossamer Bio, Inc. GOSS|KALV - Prakiraan rega marang bathi|Septerna - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Pieris Pharma PVLA|Savara Corp (SVRA) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep RIGL|ANAB (AnaptysBio, Inc.) - Pangali Forward P/E|ATXS - Pangali forward rega marang bathi|Prakiraan rega marang bathi ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E JBIO (Aerovate Therapeutics)|Pangali forward rega marang bathi Aclaris Therapeutics, Inc|KYTX - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TLSA (tizianalifesciences.com)|Cabaletta Bio (CABA) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Ventyx Biosciences Inc. (VTYX)|Prakiraan rega marang bathi THTX|Pangali Forward P/E Avalo Therapeutics Inc|Rega marang bathi mangsa ngarep Eledon Pharmaceuticals (ELDN)|AGEN: Rasio rega marang bathi sing dikarepake|Climb Bio - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ZURA|ATYR - Rega marang bathi mangsa ngarep|ADAG (Adagene) - Rasio rega marang bathi mangsa ngarep|IMA (ikenaoncology.com) - Prakiraan rega marang bathi|STTK - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi EQ|Rega marang bathi mangsa ngarep CNTB|Prakiraan rega marang bathi IMUX (Immunic, Inc.)|Kapitalisasi marang proyeksi bathi atarabio.com|Rega marang bathi mangsa ngarep InflaRx IFRX|XFOR (x4pharma.com) - Rasio rega marang bathi sing dikarepake|Adicet - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi CELU (Celularity Inc.)|INMB: Pangali Forward P/E|Barinthus Biotherapeutics Corp (BRNS) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Kezar Life Sciences|SABS: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Akari Therapeutics Plc (AKTX)|ENLV: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E QTTB (Q32 Bio)|Pangali mangsa ngarep rega marang bathi GOVX|Edesa Biotech, Inc. - Pangali Forward P/E|IBIO - Pangali Forward P/E|carismatx.com (CARM) - Rega marang bathi mangsa ngarep|XTL Biopharmaceuticals Ltd - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Bolt Biotherapeutics Inc.|Prakiraan rega marang bathi HCW Biologics Inc (HCWB)|Pangali Forward P/E APVO|Pangali Forward P/E AIM ImmunoTech, Inc. (AIM)|Aditxt, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi GRI|XORTX - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi indaptusrx.com|Rega marang bathi mangsa ngarep Scinai Immunotherapeutics Ltd.|Prakiraan rega marang bathi CalciMedica Corp (CALI)|Prakiraan rega marang bathi AFMD (Affimed)|Pangali Forward P/E allakos.com (ALLK)|Rega marang bathi mangsa ngarep HOOKIPA Pharma HOOK|IGMS: Rasio rega marang bathi mangsa ngarep|iTeos Therapeutics, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi Ocean Biomedical Inc|TC BioPharm (Holdings) PLC (TCBP) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake THRD (Third Harmonic Bio Inc)
